Business

Drug at heart of multibillion-dollar 'biosimilar' battle offered for $40 million upfront – The Enterprise Journals

Photo of Daily SF News Daily SF NewsJune 27, 2024
0 0 Less than a minute



Drug at center of multibillion-dollar ‘biosimilar’ fight sold for $40 million upfront  The Business Journals



Source link

Photo of Daily SF News Daily SF NewsJune 27, 2024
0 0 Less than a minute
Photo of Daily SF News

Daily SF News

Related Articles

San Francisco Fed boss urges calm amid fears of stagflation

San Francisco Fed boss urges calm amid fears of stagflation

June 25, 2024
San Francisco extends ‘First 12 months Free’ program that waived .5M in charges to new companies and ones struggling to remain open

San Francisco extends ‘First 12 months Free’ program that waived $2.5M in charges to new companies and ones struggling to remain open

June 8, 2024

In shutdown of gene remedy manufacturing facility, Astellas closes Bay Space biotech chapter – The Enterprise Journals

June 28, 2024
Silicon Valley billionaires pause plans for 0 million utopian metropolis – Enterprise Insider

Silicon Valley billionaires pause plans for $800 million utopian metropolis – Enterprise Insider

July 25, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *

© Copyright 2025, All Rights Reserved  | 
Back to top button